Effect of a multimethod quality improvement intervention on antipsychotic medication use among residents of long-term care

被引:0
|
作者
Hanson, Heather M. [1 ,2 ]
Leveille, Tova [3 ]
Cole, Mollie [1 ]
Soril, Lesley J. J. [2 ,4 ]
Clement, Fiona [2 ,4 ]
Wagg, Adrian [1 ,5 ]
Silvius, James [1 ,2 ]
机构
[1] Alberta Hlth Serv, Seniors Hlth Strateg Clin Network, Edmonton, AB, Canada
[2] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[3] Alberta Hlth Serv, Data & Analyt, Calgary, AB, Canada
[4] Univ Calgary, Hlth Technol Assessment Unit, Calgary, AB, Canada
[5] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada
关键词
quality improvement; collaborative; breakthrough groups; nursing homes; PDSA; performance measures; ATYPICAL ANTIPSYCHOTICS; PSYCHOLOGICAL SYMPTOMS; DEMENTIA; EFFICACY; SAFETY;
D O I
10.1136/bmjoq-2020-001211
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Antipsychotic medications are used to address neuropsychiatric symptoms associated with dementia. Evidence suggests that among older adults with dementia, their harms outweigh their benefits. A quality improvement initiative was conducted to address inappropriate antipsychotic medication use in long-term care (LTC) in the province of Alberta. Methods We conducted a multimethod evaluation of the provincial implementation of the project in 170 LTC sites over a 3-year project period incorporating a quasi-experimental before-after design. Using a three-component intervention of education and audit and feedback delivered in a learning workshop innovation collaborative format, local LTC teams were supported to reduce the number of residents receiving antipsychotic medications in the absence of a documented indication. Project resources were preferentially allocated to supporting sites with the highest baseline antipsychotic medication use. Changes in antipsychotic medication use, associated clinical and economic outcomes, and the effects of the project on LTC staff, physicians, leaders and administrators, and family members of LTC residents were assessed at the conclusion of the implementation phase. Results The province-wide initiative was delivered with a 75% implementation fidelity. Inappropriate antipsychotic medication use declined from 26.8% to 21.1%. The decrease was achieved without unintended consequences in other outcomes including physical restraint use or aggressive behaviours. The project was more expensive but resulted in less inappropriate use of antipsychotics than the pre-project period (incremental cost per inappropriate antipsychotic avoided of $5 678.71). Accounts from family, organisational leaders, and LTC staff were supportive of the project activities and outcomes. Conclusion This quality improvement initiative was successfully delivered across an entire delivery arm of the continuing care sector. Quality of care in LTC was improved.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The Association of Antipsychotic Use with Care Transitions among Long-Term Care Residents
    Holmes, S.
    Kuzucan, A.
    Brandt, N.
    Qato, D.
    Zarowitz, B.
    Wastila, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S85 - S85
  • [2] Antipsychotic Medication Use Among Newly Admitted Long-term Care Residents During the COVID-19 Pandemic in Canada
    Turcotte, Luke A.
    Heckman, George A.
    Mcarthur, Caitlin
    Saari, Margaret
    Sinn, Chi-Ling Joanna
    Mathias, Krista
    Khowaja, Asif
    Stall, Nathan M.
    Hirdes, John P.
    HEALTH SERVICES INSIGHTS, 2024, 17
  • [3] A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents
    Andrea Foebel
    Anna Ballokova
    Nathalie IH Wellens
    Daniela Fialova
    Koen Milisen
    Rosa Liperoti
    John P Hirdes
    BMC Geriatrics, 15
  • [4] A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents
    Foebel, Andrea
    Ballokova, Anna
    Wellens, Nathalie Ih
    Fialova, Daniela
    Milisen, Koen
    Liperoti, Rosa
    Hirdes, John P.
    BMC GERIATRICS, 2015, 15
  • [5] Medication Use by Elderly Residents in Long-Term Care Facilities
    Ganassin, Amanda R.
    de Matos, Vanessa T. G.
    Pina, Isabela M.
    de Souza, Albert S.
    Toffoli-Kadri, Monica C.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (10): : 1711 - 1717
  • [6] Prevalence of Antipsychotic Use in Long-Term Care Residents with Parkinson Dementia
    Zarowitz, Barbara J.
    GERIATRIC NURSING, 2012, 33 (03) : 217 - 219
  • [7] Trends in antipsychotic prescribing among long-term care residents receiving hospice care
    Gerlach, Lauren B.
    Fashaw, Shekinah
    Strominger, Julie
    Ogarek, Jessica
    Zullo, Andrew R.
    Daiello, Lori A.
    Teno, Joan
    Shireman, Theresa I.
    Bynum, Julie P. W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (08) : 2152 - 2162
  • [8] ATYPICAL ANTIPSYCHOTIC USE AMONG LONG-TERM CARE RESIDENTS WITH PARKINSON'S DISEASE AND COMORBID DEPRESSION
    Chekani, F.
    Johnson, M. L.
    Chen, H.
    Sherer, J. T.
    Holmes, H. M.
    Aparasu, R. R.
    VALUE IN HEALTH, 2018, 21 : S204 - S204
  • [9] Antipsychotic and sedative medication use in long-term care facilities providing dementia care
    Ma'u, Etuini
    Burton, Janine
    Fussell, Elizabeth
    NEW ZEALAND MEDICAL JOURNAL, 2021, 134 (1537) : 56 - 65
  • [10] Patterns of Antipsychotic Dispensation to Long-Term Care Residents
    Trenaman, Shanna C.
    von Maltzahn, Maia
    Sketris, Ingrid
    Tamim, Hala
    Wang, Yan
    Stewart, Samuel A.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (02) : 185 - 191.e6